VPS26C
Vacuolar protein sorting-associated protein 26C
Also known as: DCRA, DSCR3, VP26C_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14972
- Gene
- VPS26C
- Ensembl
- ENSG00000157538
- Chromosome
- 21
- Canonical length
- 297 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Mitochondria
OverviewNCBI Gene
The region of chromosome 21 between genes CBR and ERG (CBR-ERG region), which spans 2.5 Mb on 21q22.2, has been defined by analysis of patients with partial trisomy 21. It contributes significantly to the pathogenesis of many characteristics of Down syndrome, including morphological features, hypotonia, and cognitive disability. The DSCR3 (Down syndrome critical region gene 3) gene is found in this region and is predictated to contain eight exons. DSCR3 is expressed in most tissues examined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>O14972|VPS26C
1 MGTALDIKIK RANKVYHAGE VLSGVVVISS KDSVQHQGVS LTMEGTVNLQ LSAKSVGVFE
61 AFYNSVKPIQ IINSTIEMVK PGKFPSGKTE IPFEFPLHLK GNKVLYETYH GVFVNIQYTL
121 RCDMKRSLLA KDLTKTCEFI VHSAPQKGKF TPSPVDFTIT PETLQNVKER ALLPKFLLRG
181 HLNSTNCVIT QPLTGELVVE SSEAAIRSVE LQLVRVETCG CAEGYARDAT EIQNIQIADG
241 DVCRGLSVPI YMVFPRLFTC PTLETTNFKV EFEVNIVVLL HPDHLITENF PLKLCRILocalizationUniProt · AlphaFold · HPA
Whether an antibody against VPS26C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- tongue: 35 nTPM
- skeletal muscle: 32 nTPM
- kidney: 31 nTPM
- liver: 28 nTPM
- duodenum: 26 nTPM
- thymus: 26 nTPM
Single-cell type
- rod photoreceptor cells: 86 nCPM
- platelets: 73 nCPM
- neutrophils: 73 nCPM
- kupffer cells: 73 nCPM
- neutrophil progenitors: 70 nCPM
- myonuclei: 69 nCPM
Immune cell
- eosinophil: 85 nTPM
- intermediate monocyte: 61 nTPM
- basophil: 59 nTPM
- non-classical monocyte: 56 nTPM
- T-reg: 55 nTPM
- total PBMC: 54 nTPM
Brain region
- white matter: 19 nTPM
- cerebellum: 18 nTPM
- thalamus: 18 nTPM
- medulla oblongata: 18 nTPM
- spinal cord: 17 nTPM
- choroid plexus: 17 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about VPS26C.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 50 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VPS26C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VPS26C as an antibody target. Whether an autoantibody or antibody against VPS26C could matter depends on whether native VPS26C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VPS26C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label VPS26C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...